HUE033655T2 - Béta-2-adrenoceptor hatású benzotiazolon vegyület sók - Google Patents
Béta-2-adrenoceptor hatású benzotiazolon vegyület sók Download PDFInfo
- Publication number
- HUE033655T2 HUE033655T2 HUE13812075A HUE13812075A HUE033655T2 HU E033655 T2 HUE033655 T2 HU E033655T2 HU E13812075 A HUE13812075 A HU E13812075A HU E13812075 A HUE13812075 A HU E13812075A HU E033655 T2 HUE033655 T2 HU E033655T2
- Authority
- HU
- Hungary
- Prior art keywords
- compound
- butoxyphenyl
- methylpropan
- ylamino
- thiazol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Claims (6)
- Βέϊ»-%~ΜΐΜ®ύψίΜ hMásd teizöiMoIoíiWf^iM sók SZABADALMI lOÉMYBObllíOL. L Az (^.)-7-(2^1 -(4-butoxifc.DÍI)-2-meUlpropán--2-i!aml-Kí.)-- DhkiroxicbI)-5--hidroxibenxoldltiazoi-^ÜID-öft aeetát só egy kristályos formáim
- 2. Az Ï. igénypont szerimi kristályos forma, melyet egy^îyap'rëôtgensttgfefûrÂf-rateiésminta lliillg a 8,8 ± 0,2A 16,4 ± 0,2*, 20,8 ± 0,2" énékek közűi kiválásion 2 théta (0) refrakciós szög értékekkel, CuK« sugárzás alkalmazásával mérve.
- 3 Gyógy ,verké\zitnten>, mely az L vagy 2, igénypontok bámtelylke szérinö vegyülei gyogyászattlaglatásos mennyiségit táBalmazza, egy vagy több |yögyákzátllag elfogadható; hordozóval egyitt,
- 4 Konibibáoiö, niely egy, az 1. mgy 2, igénypont szernüi vegyfo^ Cgy vagy több gvogydszatilag aktív kö-ágenst: ttóateaz.
- 5, Az I·.· vagy 2. igénypontok bármelyikémmmti vegyidet, gyógyszetkénktörténö aL katoazásra.
- 6, Az I. vagy 2. Igénypöbíok bátMélylke szerinti vegyülét, Izontsorvadásna betegségek kezelésében vagy megelőzésében való alkalntazlpa-: % A: 4 igénypont szerinti vegyüld, ahol az izomaorvadásos betegség a muscuiam dystrophia, használaton kívüliség okozta atrophia, cachexia vagy szarkopénia.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IQ23912 | 2012-08-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE033655T2 true HUE033655T2 (hu) | 2017-12-28 |
Family
ID=53386469
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE13812075A HUE033655T2 (hu) | 2012-08-30 | 2013-08-29 | Béta-2-adrenoceptor hatású benzotiazolon vegyület sók |
Country Status (27)
| Country | Link |
|---|---|
| EP (2) | EP2890687B1 (hu) |
| KR (1) | KR20150047586A (hu) |
| CN (2) | CN104736525B (hu) |
| BR (1) | BR112015004127A2 (hu) |
| CA (1) | CA2882877A1 (hu) |
| CL (1) | CL2015000461A1 (hu) |
| CY (1) | CY1120225T1 (hu) |
| DK (1) | DK2890687T3 (hu) |
| EA (1) | EA029946B1 (hu) |
| ES (1) | ES2642003T3 (hu) |
| HK (1) | HK1206015A1 (hu) |
| HR (1) | HRP20171362T1 (hu) |
| HU (1) | HUE033655T2 (hu) |
| IL (1) | IL237382A0 (hu) |
| LT (1) | LT2890687T (hu) |
| MA (1) | MA37872A1 (hu) |
| MX (1) | MX351741B (hu) |
| MY (1) | MY169038A (hu) |
| NZ (1) | NZ705319A (hu) |
| PE (1) | PE20150465A1 (hu) |
| PL (1) | PL2890687T3 (hu) |
| PT (1) | PT2890687T (hu) |
| SA (1) | SA515360076B1 (hu) |
| SG (2) | SG11201501293PA (hu) |
| SI (1) | SI2890687T1 (hu) |
| TN (1) | TN2015000058A1 (hu) |
| WO (1) | WO2014033654A1 (hu) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO3192B1 (ar) * | 2011-09-06 | 2018-03-08 | Novartis Ag | مركب بنزوثيازولون |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR040962A1 (es) | 2002-08-09 | 2005-04-27 | Novartis Ag | Compuestos derivados de tiazol 1,3-2-ona, composicion farmaceutica y proceso de preparacion del compuesto |
| CA2514733A1 (en) | 2003-02-28 | 2004-09-16 | Transform Pharmaceuticals, Inc. | Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen |
| JP2007537187A (ja) | 2004-05-13 | 2007-12-20 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 呼吸器疾患の治療においてβアゴニストとして使用するためのヒドロキシ置換ベンゾ縮合ヘテロ環化合物 |
| GB0426164D0 (en) * | 2004-11-29 | 2004-12-29 | Novartis Ag | Organic compounds |
| JO3192B1 (ar) * | 2011-09-06 | 2018-03-08 | Novartis Ag | مركب بنزوثيازولون |
| AU2014222362B2 (en) * | 2013-02-28 | 2016-07-21 | Novartis Ag | Formulation comprising benzothiazolone compound |
-
2013
- 2013-08-29 HU HUE13812075A patent/HUE033655T2/hu unknown
- 2013-08-29 KR KR1020157007573A patent/KR20150047586A/ko not_active Application Discontinuation
- 2013-08-29 SI SI201330750T patent/SI2890687T1/sl unknown
- 2013-08-29 CA CA2882877A patent/CA2882877A1/en not_active Abandoned
- 2013-08-29 EP EP13812075.3A patent/EP2890687B1/en active Active
- 2013-08-29 MA MA37872A patent/MA37872A1/fr unknown
- 2013-08-29 PT PT138120753T patent/PT2890687T/pt unknown
- 2013-08-29 LT LTEP13812075.3T patent/LT2890687T/lt unknown
- 2013-08-29 SG SG11201501293PA patent/SG11201501293PA/en unknown
- 2013-08-29 MX MX2015002656A patent/MX351741B/es active IP Right Grant
- 2013-08-29 DK DK13812075.3T patent/DK2890687T3/en active
- 2013-08-29 PL PL13812075T patent/PL2890687T3/pl unknown
- 2013-08-29 NZ NZ705319A patent/NZ705319A/en not_active IP Right Cessation
- 2013-08-29 ES ES13812075.3T patent/ES2642003T3/es active Active
- 2013-08-29 SG SG10201704377PA patent/SG10201704377PA/en unknown
- 2013-08-29 PE PE2015000275A patent/PE20150465A1/es not_active Application Discontinuation
- 2013-08-29 CN CN201380055093.1A patent/CN104736525B/zh not_active Expired - Fee Related
- 2013-08-29 BR BR112015004127A patent/BR112015004127A2/pt not_active Application Discontinuation
- 2013-08-29 EP EP17171708.5A patent/EP3243817A1/en not_active Withdrawn
- 2013-08-29 WO PCT/IB2013/058109 patent/WO2014033654A1/en active Application Filing
- 2013-08-29 EA EA201590452A patent/EA029946B1/ru not_active IP Right Cessation
- 2013-08-29 CN CN201610537241.9A patent/CN106146428A/zh active Pending
- 2013-08-29 MY MYPI2015000453A patent/MY169038A/en unknown
-
2015
- 2015-02-20 TN TNP2015000058A patent/TN2015000058A1/fr unknown
- 2015-02-23 IL IL237382A patent/IL237382A0/en unknown
- 2015-02-25 CL CL2015000461A patent/CL2015000461A1/es unknown
- 2015-02-26 SA SA515360076A patent/SA515360076B1/ar unknown
- 2015-07-08 HK HK15106522.7A patent/HK1206015A1/xx not_active IP Right Cessation
-
2017
- 2017-09-11 HR HRP20171362TT patent/HRP20171362T1/hr unknown
- 2017-09-13 CY CY20171100967T patent/CY1120225T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EA201590452A1 (ru) | 2015-07-30 |
| MX2015002656A (es) | 2015-05-20 |
| HRP20171362T1 (hr) | 2017-11-03 |
| WO2014033654A1 (en) | 2014-03-06 |
| IL237382A0 (en) | 2015-04-30 |
| PL2890687T3 (pl) | 2017-11-30 |
| TN2015000058A1 (en) | 2016-06-29 |
| MX351741B (es) | 2017-10-26 |
| EP2890687A1 (en) | 2015-07-08 |
| KR20150047586A (ko) | 2015-05-04 |
| EP2890687B1 (en) | 2017-06-28 |
| HK1206015A1 (en) | 2015-12-31 |
| SA515360076B1 (ar) | 2016-03-20 |
| CY1120225T1 (el) | 2018-12-12 |
| PE20150465A1 (es) | 2015-04-22 |
| MY169038A (en) | 2019-02-07 |
| MA37872A1 (fr) | 2018-07-31 |
| BR112015004127A2 (pt) | 2017-07-04 |
| SG10201704377PA (en) | 2017-06-29 |
| CN104736525B (zh) | 2016-08-24 |
| EA029946B1 (ru) | 2018-06-29 |
| CL2015000461A1 (es) | 2015-05-04 |
| SG11201501293PA (en) | 2015-03-30 |
| ES2642003T3 (es) | 2017-11-14 |
| SI2890687T1 (sl) | 2017-10-30 |
| EP3243817A1 (en) | 2017-11-15 |
| CN104736525A (zh) | 2015-06-24 |
| LT2890687T (lt) | 2017-09-11 |
| NZ705319A (en) | 2018-05-25 |
| CA2882877A1 (en) | 2014-03-06 |
| PT2890687T (pt) | 2017-10-05 |
| DK2890687T3 (en) | 2017-10-09 |
| CN106146428A (zh) | 2016-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10251868B2 (en) | Benzothiazolone compound | |
| EP2729454B1 (en) | Novel trifluoromethyl-oxadiazole derivatives and their use in the treatment of disease | |
| DK2961391T3 (en) | Formulation comprising a benzothiazolone compound | |
| DK2890687T3 (en) | Salts of benzothiazolone compound as beta-2-adrenoceptor agonist | |
| WO2020210597A1 (en) | Benzimidazole derivatives and their uses | |
| NZ621089B2 (en) | Benzothiazolone compound |